1282516-67-9,MFCD22372760
Catalog No.:AA009W8V

1282516-67-9 | 9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$46.00   $32.00
- +
1g
98%
in stock  
$120.00   $84.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA009W8V
Chemical Name:
9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
CAS Number:
1282516-67-9
Molecular Formula:
C11H9BrN2O
Molecular Weight:
265.1060
MDL Number:
MFCD22372760
SMILES:
Brc1ccc2c(c1)OCCn1c2ncc1
Properties
Computed Properties
 
Complexity:
239  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[4]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[6]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

[1]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1Locationinpatent:Page/Pagecolumn69;72;73

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1Locationinpatent:Paragraph0150;0169-0170

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1Locationinpatent:Paragraph0113;0131-0133

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1Locationinpatent:Page/Pagecolumn108

[7]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,ALocationinpatent:Paragraph0193;0199-0202

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[8]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[9]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[1]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1Locationinpatent:Paragraph0113;0134-0136

[2]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,ALocationinpatent:Paragraph0193;0203-0206

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1Locationinpatent:Page/Pagecolumn17;19;20

[4]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1Locationinpatent:Page/Pagecolumn69;73

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1Locationinpatent:Paragraph0150;0171-0172

[7]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[8]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1Locationinpatent:Page/Pagecolumn108

[9]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1282516-67-9
Tags:1282516-67-9 Molecular Formula|1282516-67-9 MDL|1282516-67-9 SMILES|1282516-67-9 9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
Catalog No.: AA009W8V
1282516-67-9,MFCD22372760
1282516-67-9 | 9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
Pack Size: 250mg
Purity: 98%
in stock
$46.00 $32.00
Pack Size: 1g
Purity: 98%
in stock
$120.00 $84.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA009W8V
Chemical Name: 9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
CAS Number: 1282516-67-9
Molecular Formula: C11H9BrN2O
Molecular Weight: 265.1060
MDL Number: MFCD22372760
SMILES: Brc1ccc2c(c1)OCCn1c2ncc1
Properties
Complexity: 239  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2  
Downstream Synthesis Route
22532-62-3    1282516-67-9 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[4]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[6]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

1282516-66-8    106-93-4    1282516-67-9 

[1]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1Locationinpatent:Page/Pagecolumn69;72;73

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1Locationinpatent:Paragraph0150;0169-0170

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1Locationinpatent:Paragraph0113;0131-0133

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1Locationinpatent:Page/Pagecolumn108

[7]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,ALocationinpatent:Paragraph0193;0199-0202

1282516-67-9    1282516-69-1 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[8]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[9]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

1282516-67-9    1282516-65-7 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

1282516-67-9    1282516-68-0 

[1]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1Locationinpatent:Paragraph0113;0134-0136

[2]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,ALocationinpatent:Paragraph0193;0203-0206

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1Locationinpatent:Page/Pagecolumn17;19;20

[4]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1Locationinpatent:Page/Pagecolumn69;73

[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1Locationinpatent:Paragraph0150;0171-0172

[7]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[8]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1Locationinpatent:Page/Pagecolumn108

[9]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

Building Blocks More >
127806-46-6
127806-46-6
2-(Piperidin-4-yloxy)pyridine
AA009WO0 | MFCD11053197
1214340-35-8
1214340-35-8
3-(2-Fluorophenyl)-4-fluorobenzoic acid
AA009WR5 | MFCD14699218
1393441-99-0
1393441-99-0
5-Bromo-6-fluoro-2-methyl-1-propylbenzodiazole
AA009WUD | MFCD22383713
1365272-16-7
1365272-16-7
2-Amino-N-isopropylbenzenesulfonamide, HCl
AA009WYN | MFCD21609501
1403483-75-9
1403483-75-9
Benzyl N-[1-(4-fluorophenyl)cyclobutyl]carbamate
AA009WZ2 | MFCD22549318
1217899-52-9
1217899-52-9
trans-Capsaicin-d3
AA009X6A | MFCD09840180
1273326-17-2
1273326-17-2
7-(Dimethylamino)benzo[c][1,2,5]thiadiazole-4-carbaldehyde
AA009WW5 | MFCD23135917
1266247-03-3
1266247-03-3
5-(Benzyloxy)-N-ethyl-2-nitroaniline
AA009WZ7 | MFCD25121748
1326713-90-9
1326713-90-9
Benzaldehyde, 3-bromo-2-[(1,1-dimethylethyl)thio]-
AA009YIC | MFCD29763335
1217033-63-0
1217033-63-0
Ethyl Myristate-d5
AA009YZJ
Submit
© 2017 AA BLOCKS, INC. All rights reserved.